Articles Tagged With: tuberculosis
-
Tuberculosis in the United States in 2017
While the incidence of tuberculosis in the United States in 2017 was the lowest ever recorded, the current rate of decline would be required to almost double to reach the goal of elimination of the disease in this country by the year 2100.
-
Self-administered Weekly Therapy for Latent Tuberculosis Is Non-inferior to Directly Observed Therapy in the United States
A randomized clinical trial conducted in the United States and three other countries compared self-administered isoniazid and rifapentine with and without weekly reminders to directly observed therapy (DOT). Self-administered therapy without reminders was non-inferior to DOT in the United States; no other comparisons met non-inferiority criteria.
-
TB in the United States: Better, but Still a Long Way to Go
The incidence of tuberculosis in the United States continues to decrease, but not at a rate sufficient to achieve elimination during this century.
-
Screening for Latent Tuberculosis: An Update After 20 Years
Detection and treatment of latent tuberculous infection remains a key element of tuberculosis control in the United States.
-
Healthcare Workers and Tuberculosis Prevention
Healthcare workers in high-burden countries in particular remain at high risk of tuberculosis.
-
TB Q&A for patients after exposure incidents
As part of notifying patients of a possible TB exposure to an infected employee, Santa Clara Valley Medical Center in San Jose, CA, issued the following “frequently asked questions” TB information for patients. Employee health professionals may want to consider something like this should they find themselves facing a similar situation:
-
Patients alarmed after newborns exposed to TB
A California hospital continues a high-stakes tuberculosis follow-up of more than 350 newborns exposed to an infected healthcare worker. With testing reliability questionable in such infants, the babies are essentially being treated empirically with isoniazid for a TB strain that is susceptible to the first line drug.
-
Infectious Disease Alert Updates
Legionella Revisited; Treatment of Latent Tuberculosis; Transmission of Clostridium difficile from Asymptomatic Carriers
-
Preventing Active Tuberculosis in Children
A three-month course of weekly rifapentine and isoniazid is safe and at least as effective as nine months of daily isoniazid in preventing tuberculosis in children aged 2 to 17 years.